US Patent Issued to MERZ PHARMA on April 14 for "High dose and low volume botulinum toxin treatment of facial wrinkles" (German Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,550, issued on April 14, was assigned to MERZ PHARMA GMBH & Co. KGAA (Frankfurt am Main, Germany).

"High dose and low volume botulinum toxin treatment of facial wrinkles" was invented by Susanna Roll (Stadecken-Elsheim, Germany), Meik Sladek (Frankfurt am Main, Germany), Thorin Geister (Frankfurt am Main, Germany), Irena Pulte (Frankfurt am Main, Germany), Petra Weissenberger (Frankfurt am Main, Germany) and Gudrun Klein (Frankfurt am Main, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates the use of botulinum toxin for the treatment of facial wrinkles, wherein botulinum toxin is administered at high doses (e.g., ...